Just pointing out that a rerate of significance would be success in trials and the resultant market cap. Dr Sud, who runs Cannvalate and is a very seasoned operator wouldn't enter into options deals of the magnitude he has if there wasn't significant upside. It is about the magnitude of what the IP is worth and we are talking hundreds of millions of Mc value at least.
Market is aware of options and is factored in already.
